BCL2L1 and neoplasm: The combination of DT2216 (15 mg/kg, q7d, ip) and ABT-199 (50 mg/kg, qd, po) induced nearly complete suppression of tumor growth in mice xenografted with NCI-H146 SCLC cells, which depend on both BCL-XL and BCL-2 for survival.